# RapidShock Post-Approval Study

> **NCT04014842** · NA · COMPLETED · sponsor: **Zoll Medical Corporation** · enrollment: 2756 (actual)

## Conditions studied

- Cardiac Arrest

## Interventions

- **DEVICE:** RapidShock

## Key facts

- **NCT ID:** NCT04014842
- **Lead sponsor:** Zoll Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-26
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 2756 (ACTUAL)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04014842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04014842, "RapidShock Post-Approval Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04014842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*